Assessment of @entity4831 Deposition and @entity5 for @entity157 After Transcatheter Arterial Chemoembolization via XXXX -Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study.

@entity1 @entity1496 @entity5 @entity4831 @entity157
BACKGROUND: It is critical to follow up @entity157 ( @entity157 ) after transcatheter arterial chemoembolization (TACE) in clinical practice. Computed tomography (CT) is used to assess @entity4831 deposition, whereas it is difficult to @entity5 masked by @entity4831 . In contrast, magnetic resonance imaging (MRI) is superior to CT in showing @entity5 , but cannot display @entity4831 deposition. OBJECTIVES: The aim of this study was to investigate the value of spectral CT imaging in both @entity4831 deposition and @entity5 for @entity157 @entity1 after TACE. @entity1 AND METHODS: Ten @entity157 @entity1 after treated with TACE underwent Discovery CT750 HD and MRI750 3T examination. Receiver operating characteristic (ROC) curves of @entity1496 -based material decomposition images, monochromatic images and conventional CT images were generated. RESULTS: Consequently, 30 residual lesions were detected in MRI of 10 @entity1 . They were found in @entity1496 -based images and monochromatic images versus 29 in conventional CT images. The area under ROC curves for the lesion-to-normal parenchyma ratio (LNR) on arterial phase (AP) in @entity1496 -based material decomposition images, monochromatic images and conventional CT images were 0.933, 0.833 and 0.817, respectively. CONCLUSION: The study data highlighted good value of @entity1496 -based material decomposition images of spectral CT in assessment of both @entity4831 deposition and @entity5 for follow-up of @entity157 @entity1 previously treated with TACE.
